| |
| |
|
| Insider
Information: |
Thorell Marella |
| Relationship: |
Chief Financial Officer |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
87,747 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,102 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
87,747 |
|
|
| Total
Value |
$1,102 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ESSA Pharma Inc |
EPIX |
Director |
2020-10-01 |
2,881 |
|
0 |
Premium* |
|
|
Centessa Pharmaceuticals Plc |
CNTA |
Chief Accounting Officer |
2022-03-21 |
53,101 |
2021-06-02 |
0 |
Premium* |
|
|
Gri Bio Ord Shs |
GRI |
Director |
2022-12-13 |
9,506 |
2022-07-01 |
0 |
Premium* |
|
|
Evelo Biosciences Inc |
EVLO |
Chief Financial Officer |
2023-11-08 |
22,259 |
2023-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-11-08 |
4 |
AS |
$0.33 |
$598 |
D/D |
(1,811) |
22,259 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-11-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
24,070 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-08-08 |
4 |
AS |
$9.51 |
$19,058 |
D/D |
(2,004) |
9,069 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
11,073 |
0 |
- |
|
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-05-08 |
4 |
AS |
$0.13 |
$4,836 |
D/D |
(38,531) |
91,469 |
0 |
% |
|
| EVLO |
Evelo Biosciences Inc |
Chief Financial Officer |
• – – |
2023-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
130,000 |
130,000 |
0 |
- |
|
| GRI |
Gri Bio Ord Shs |
Director |
– • – |
2022-12-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(28,517) |
9,506 |
0 |
- |
|
| GRI |
Gri Bio Ord Shs |
Director |
– • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
38,023 |
38,023 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Accounting Officer |
• – – |
2022-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
52,101 |
53,101 |
0 |
- |
|
| CNTA |
Centessa Pharmaceuticals ... |
Chief Accounting Officer |
• – – |
2021-06-02 |
4 |
B |
$20.00 |
$20,000 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| EPIX |
ESSA Pharma Inc |
Director |
– • – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,881 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
